Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
1676
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $7.05M | ﹤0.01% |
65,200
-30,000
| -32% | -$3.21M |
|
|
FOLD
1677
DELISTED
Amicus Therapeutics
FOLD
| $7.05M | ﹤0.01% |
723,907
+497,092
| +219% | +$4.55M |
|
1678
Coty
COTY
$2.48B
| $7.05M | ﹤0.01% |
626,287
+186,072
| +42% | +$2.12M |
|
1679
Alnylam Pharmaceuticals
ALNY
$29.3B
| $7.04M | ﹤0.01% |
61,158
-39,729
| -39% | -$3.96M |
|
1680
Avis
CAR
$5.02B
| $7.04M | ﹤0.01% |
218,455
-37,539
| -15% | -$1.13M |
|
|
EV
1681
DELISTED
Eaton Vance Corp.
EV
| $7.04M | ﹤0.01% |
150,688
-20,896
| -12% | -$966K |
|
|
RETA
1682
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $7.03M | ﹤0.01% |
34,405
+24,495
| +247% | +$4.47M |
|
|
DOCU
1683
PUT
DocuSign
DOCU
$11.5B
| $7.03M | ﹤0.01% |
94,900
-42,000
| -31% | -$2.89M |
|
1684
J&J Snack Foods
JJSF
$1.71B
| $7.03M | ﹤0.01% |
38,135
+15,121
| +66% | +$2.85M |
|
1685
PUT
Ionis Pharmaceuticals
IONS
$9.4B
| $7.01M | ﹤0.01% |
116,100
+12,500
| +12% | +$745K |
|
1686
Dick's Sporting Goods
DKS
$18.7B
| $7.01M | ﹤0.01% |
141,707
-197,463
| -58% | -$8.4M |
|
1687
CALL
Wheaton Precious Metals
WPM
$60.9B
| $7.01M | ﹤0.01% |
235,700
+117,000
| +99% | +$3.2M |
|
1688
PUT
Hormel Foods
HRL
$13.8B
| $7M | ﹤0.01% |
155,200
-800
| -0.5% | -$34.4K |
|
1689
Ambarella
AMBA
$3.81B
| $7M | ﹤0.01% |
115,602
-17,494
| -13% | -$969K |
|
1690
CALL
Sun Communities
SUI
$14.7B
| $7M | ﹤0.01% |
+46,600
| New | +$7.26M |
|
|
INST
1691
DELISTED
Instructure, Inc.
INST
| $6.99M | ﹤0.01% |
145,039
+119,828
| +475% | +$5.62M |
|
1692
Darling Ingredients
DAR
$9.44B
| $6.99M | ﹤0.01% |
248,886
+57,442
| +30% | +$1.28M |
|
1693
CALL
Twilio
TWLO
$36.6B
| $6.98M | ﹤0.01% |
71,000
-54,800
| -44% | -$5.6M |
|
1694
Performance Food Group
PFGC
$18B
| $6.97M | ﹤0.01% |
135,489
+26,719
| +25% | +$1.22M |
|
|
MYOK
1695
PUT
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $6.97M | ﹤0.01% |
+95,600
| New | +$5.8M |
|
|
JAG
1696
DELISTED
Jagged Peak Energy Inc.
JAG
| $6.96M | ﹤0.01% |
820,365
+754,889
| +1,153% | +$5.52M |
|
|
QTS
1697
DELISTED
QTS REALTY TRUST, INC.
QTS
| $6.96M | ﹤0.01% |
128,245
+56,740
| +79% | +$2.97M |
|
1698
British American Tobacco
BTI
$128B
| $6.96M | ﹤0.01% |
163,869
+131,636
| +408% | +$4.96M |
|
1699
PUT
Waste Management
WM
$91B
| $6.95M | ﹤0.01% |
61,000
+8,400
| +16% | +$949K |
|
1700
Clean Harbors
CLH
$16.3B
| $6.95M | ﹤0.01% |
81,040
-17,961
| -18% | -$1.46M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.